cancer

FDA approves olaparib/abiraterone combination for BRCA+ metastatic castration-resistant prostate cancer

by

The FDA has approved olaparib (Lynparza) plus abiraterone and prednisone or prednisolone for the treatment of patients with deleterious or suspected BRCA-mutated metastatic castration-resistant prostate cancer, as determined by an accompanying FDA-approved diagnostic test.1 The regulatory decision is supported by results from the Phase 3 PROpel study (NCT03732820) in which the olaparib regimen significantly improved … Read more

How medical recoding may limit options for breast reconstruction for cancer patients

by

The federal government is reconsidering a decision that breast cancer patients, plastic surgeons and members of Congress have protested would limit women’s options for reconstructive surgery. On June 1, the Centers for Medicare & Medicaid Services plans to review how doctors are paid for a type of breast reconstruction known as a DIEP flap, in … Read more

Tips for managing medical bills during cancer

by

Transcription: Kristie L.Kahl: After receiving a diagnosis, why is it important for patients to understand its benefits? What should they look for in particular? Monica Fawzy Bryant, Esq: At Triage Cancer, we think there should be a high school lesson in understanding health insurance and finances, because everyone needs to understand this. But we’re never … Read more

Single Dose Of Psilocybin Causes Long-Term Remission Of Depression In Over 50% Of Cancer Patients | Psychedelic spotlight

by

Great news for those researching new treatments for depression in cancer patients! Positive long-term follow-up data has just been released from Sunstone Therapies investigator-initiated Phase 2 study evaluating synthetic psilocybin COMPASS Pathways, with some rather promising results. Administration of a single 25 mg dose of psilocybin combined with psychological support resulted in 57% of patients … Read more

We will see our children grow up on the cancer drug funded by Sun readers

by

A LIFE-CHANGING cancer drug launched on the NHS thanks to money raised by brilliant Sun readers over 20 years ago. Doctors approved the chemotherapy medicine olaparib in April for patients with breast and prostate cancers with certain genetic mutations. Joannah Kelly says new cancer drug olaparib extended her life and thanks Sun readersCredit: Louis Wood … Read more

As cancer drug shortages grow, some doctors are forced to ration doses or delay treatment

by

Widespread cancer drug shortages are forcing doctors to make difficult decisions about how to treat their patients, including dose rationing and switching to other treatment options with potentially more side effects. As of Wednesday, the Food and Drug Administration has listed 14 cancer drugs in short supply. The oncology shortage is especially critical, FDA Commissioner … Read more